具有谷胱甘肽过氧化物酶活力的含硒三肽

合成了由硒代半胱氨酸(U)、谷氨酰胺(Q)和色氨酸(W)组成的QUW,QWU,WQU,WUQ,UWQ和UQW 6个具有谷胱甘肽过氧化物酶(GPx)活力的含硒三肽;采用双酶偶联法进行了GPx活力测定和稳态动力学分析;通过噻唑蓝(MTT)比色法、划痕愈合实验和Western blot技术表征了含硒三肽对肝癌Hep G2细胞生长和迁移能力的影响.结果表明,当U位于氨基端时,含硒三肽的GPx活力高于U位于中间位置或者羧基端时.UWQ催化谷胱甘肽(GSH)还原H2O2的活力最高,其催化机制为乒乓机制.UWQ可使Hep G2细胞运动能力减弱,降低肝癌细胞的浸润转移能力.     

具有谷胱甘肽过氧化物酶活性的催化抗体的研究：Ⅰ.谷胱甘肽特征全抗…

用２，４－二硝基氯苯保护谷胱甘肽的巯基制出半抗原，再通过戊二醛共价反应使其与牛血清白蛋白表面的氨基结合，经超胶ＡｃＡ５４凝胶层析纯化，制备出有较强免疫原性的谷胱甘肽全抗原，用元素分析、红外光谱及核磁共振表征了半抗原的结构，电泳分析得全抗原分子量平均为８７０００道尔顿，光谱分析及圆二色谱研究表明其有较强的可强，紫外及荥光特征吸收，且抗原结构的紧密性增强。     

活力高于天然谷胱甘肽过氧化物酶的含硒抗体酶

还原型谷胱甘肽(GSH)的巯基和两个羧基分别与2,4-二硝基氯苯(DNCB)和甲醇反应,合成出半抗原Hp2;通过戊二醛将Hp2连到牛血清白蛋白(BSA)上,合成出全抗原Ag2;吸收光谱法测出Hp2在BSA上的平均连接量为30.2mol/mol.用标准的单克隆抗体(McAb)制备技术,制备出阳性McAb(IgG)-4G3;4G3对GSH和半抗原Hp2的解离常数(K_D)表明,单克隆抗体4G3对GSH具有较强的亲和力.对4G3进行两步化学诱变(Chemical Mutation),诱变后即为具有谷胱甘肽过氧化物酶(GPX)活性的含硒抗体酶(m4G3),m4G3的GPX活力为9337U/μmol,是兔肝GPX(RL-GPX,5780U/μmol)的 1.6倍,曾报道的含硒抗体酶m4A4(1239 U/μmol)的7.5倍,制备出活性高于天然酶的抗体酶,证实了半抗原设计思想.将m4G3拆分成Fab和Fc片段,发现m4G3的活性中心位于Fab片段上,m4G3的硒代半胱氨酸(Se-Cys)含量为1.9 mol/mol.     

量子点与人源抗谷胱甘肽单链抗体的连接与表征

用已构建的表达载体pPELB-B3, 在大肠杆菌Rosetta中可溶性表达人源抗谷胱甘肽(GSH)单链抗体B3(scFv-B3), 经Ni2+螯合亲和层析纯化后, 用点印迹法验证了其与GSH结合的特异性. 将水相合成的半导体纳米粒子(半导体量子点, QDs)在N-羟基琥珀酰亚胺(NHS)和1-乙基-3-(3-二甲基氨基丙基)碳酰二亚胺盐酸盐(EDC)的作用下, 与scFvs连接. 光谱分析和膜印迹结果表明, scFvs成功地共价连接到QDs表面, 所得的QD-scFvs复合物能够较好地识别GSH. 荧光显微镜观察QD-scFvs与人乳腺癌细胞MCF-7的作用结果, 初步判断QD-scFvs能够跨膜进入细胞.     

具有谷胱甘肽过氧化物酶(GPx)活力的含硒四肽(SecRGD)

以精氨酸-甘氨酸-天冬氨酸(RGD)序列为基础, 在N-端引入硒代半胱氨酸(Sec)设计了SecRGD序列模拟谷胱甘肽过氧化物酶(GPx), 利用Fmoc固相合成法合成了SecRGD. 采用ESI-MS质谱和氢化物原子荧光光谱法对硒肽进行表征, 采用酶偶联法进行GPx活力测定和酶动力学分析, 用噻唑蓝(MTT)比色法评价了硒肽的抗氧化效果. 结果表明, 该硒肽的存在形式为SecRGD的二聚体. 该硒肽具有GPx活力, 其催化谷胱甘肽(GSH)还原H2O2的GPx活力为5.54 U/μmol, 高于经典的GPx模拟物Ebselen. 稳态动力学分析结果表明, 该硒肽的催化机制为乒乓机制. 该硒肽具有分子量小, 易溶于水, 毒性低及可有效保护Vero细胞免受氧化损伤的优点, 具有作为抗氧化药物的应用前景.     

可溶性人源含硒抗体酶GPx的研究

对噬菌体展示人单链抗体库进行筛选,得到与半抗原S-二硝基苯取代的谷胱甘肽二丁酯特异结合的单链抗体3B10。用计算机模拟分析了单链抗体的空间结构,发现抗原结合的CDR3区位于抗体的表面,推测其可能进一步参加硒化反。利用突变引物,在大肠杆菌中表达了可溶性抗体蛋白,并用化学方法将催化必需基团硒代半胱氨酸（Sec）组装到3B10抗原结合部位,获得了具有谷胱甘肽过氧化酶活力的人源抗体酶。动力学研究结果表明,抗体酶和天然酶一样,符合乒乓反应机制。     

通过快速定点突变表征人源含硒单链抗体酶的底物结合部位

为了对人源含硒单链抗体酶Se-scFv-B3的底物结合部位和催化基团进行研究, 在理论预测的基础上, 通过快速定点突变法分别在2个理论预测的底物结合部位(位点1和位点2)内选定Ala180和Ala44定点突变为丝氨酸(Ser). 2个突变体蛋白经化学修饰将Ser转变成谷胱甘肽过氧化物酶(GPX)的催化基团硒代半胱氨酸(Sec)后, 前者的GPX活力达到了Se-scFv-B3的2倍多, 而后者的GPX活力没有明显提高, 这表明位点1可能是主要的底物结合部位, 与理论预测的结果一致.     

以蛋白质为基础模拟谷胱甘肽过氧化物酶

硒元素作为一种生命体中必须的微量元素,与人类的健康和疾病息息相关.硒元素主要以硒代半胱氨酸的形式存在于至少25种硒蛋白中,执行着多种生物功能.在这20多种硒蛋白中,谷胱甘肽过氧化物酶(GPx)作为一种主要的抗氧化酶,能够有效地利用谷胱甘肽还原氢过氧化物以防止机体的氧化损伤.这里,我们主要介绍以蛋白质为骨架构筑GPx模拟物的一些策略和方法,以期望于能够更好的理解硒蛋白的生物学性质,甚至开拓更为有效的技术去模拟这种抗氧化酶.     

具有谷胱甘肽过氧化物酶活性的催化抗体的研究Ⅰ．谷胱甘肽特征全抗原的合成、表征及性质

用２，４－二硝基氯苯保护谷胱甘肽的巯基制出半抗原，再通过戊二醛共价反应使其与牛血清白蛋白表面的氨基结合，经超胶ＡｃＡ５４凝胶层析纯化，制备出有较强免疫原性的谷胱甘肽全抗原。用元素分析、红外光谱及核磁共振表征了半抗原的结构。电泳分析得全抗原分子量平均为８７０００道尔顿。光谱分析及圆二色谱研究表明其有较强的可见、紫外及荧光特征吸收，且抗原结构的紧密性增强。     

以蛋自质为基础模拟谷胱甘肽过氧化物酶

硒元素作为一种生命体中必须的微量元素,与人类的健康和疾病息息相关.硒元素主要以硒代半胱氨酸的形式存在于至少25种硒蛋白中,执行着多种生物功能.在这20多种硒蛋白中,谷胱甘肽过氧化物酶( GPx)作为一种主要的抗氧化酶,能够有效地利用谷胱甘肽还原氢过氧化物以防止机体的氧化损伤.这里,我们主要介绍以蛋白质为骨架构筑GPx模...     

具有GPX活力的抗体片段Fv的制备和性质

具有谷胱甘肽(GSH)结合部位的鼠抗体3H₄(IgM)经胃蛋白酶水解,产生分子量为25000的抗体Fv片段,用荧光滴定法测定了它与GSH的亲和常数K_a=1.17×10₇L/mol.该片段经苯甲基磺酰氟活化,再经NaHSe作用,其结合部位的丝氨酸被突变为谷胱甘肽过氧化物酶(GPX)的催化基团硒代半胱氨酸.突变后的Fv片段表现出很高的GPX活性,其活力高达2500U/μmol,称为Fv抗体酶.动力学分析表明,Fv酶的最适温度为55℃,最适pH为7.0,催化机制为乒乓机制,米氏常数分别为:K_m(GSH)=4.16×10^-3mol/L,K_m(H₂O₂)=2.8×10^-4mol/L.     

Rapid Selection of Phage Se-scFv with GPX Activity via Combination of Phage Display Antibody Library with Chemical Modification

IntroductionReactive oxygen species(ROS) are known to de-stroy biomacromolecules and cause cell injury[1]. Un-der normal circumstances, there is a balance betweenthe production of ROS and their destruction. Many dis-eases, such as brain ischemia, tumor, v…     

Antioxidant Effect of Human Selenium-containing Single-chain Fv in Rat Cardiac Myocytes

Reactive oxygen species(ROS) plays a key role in human heart diseases.Glutathione peroxidase(GPX) functions as an antioxidant as it catalyzes the reduction of hydroperoxide.In order to investigate the antioxidant effect of human selenium-containing single-chain Fv(Se-scFv-B3),a new mimic of GPX,a model system of hydrogen peroxide(H2O2)-induced rat cardiac myocyte damage was established.The cardiac myocyte damage was characterized in terms of cell viability,lipid peroxidation,cell membrane integrity,and intracellular H2O2 level.The Se-scFv-B3 significantly reduced H2O2-induced cell damage as shown by the increase of cell viability,the decline of malondialdehyde(MDA) production,lactate dehydrogenase(LDH) release,and intracellular H2O2 level.So Se-scFvB3 may have a great potential in the treatment of human heart diseases induced by ROS.     

Novel Selenium-containing Human Single-chain Variable Fragment with Glutathione Peroxidase Activity from Computer-aided Molecular Design

In order to enhance the glutathione peroxidase(GPX) catalytic activity of the selenium-containing single-chain variable fragments(Se-scFv), a novel human scFv was designed on the basis of the structure of human antibody and optimized via bioinformatics methods such as homologous sequence analysis, three-dimensional(3D) model building, binding-site analysis and docking. The DNA sequence of the new human scFv was synthesized and cloned into the expression vector pET22b(+), then the scFv protein was expressed in soluble form in Escherichia coli BL21(DE3) and purified by Ni2+-immobilized metal affinity chromatography(IMAC). The serine residue of scFv in the active site was converted into selenocysteine(Sec) with the chemical modification method, thus, the human Se-scFv with GPX activity was obtained. The GPX activity of the Se-scFv protein was characterized. Compared with other Se-scFv, the new human Se-scFv showed similar efficiency for catalyzing the reduction of hydrogen peroxide by glutathione. It exhibited pH and temperature dependent catalytic activity and a typical ping-pong kinetic mecha- nism.     

具有cGPX活力的含硒抗体酶的酶学及动力学性质研究

通过单克隆抗体制备技术得到三株特异结合半抗原4(GSH-S-DNP二苄酯)的单克隆抗体HB4,HB5和HB7.抗体经两步化学诱变得到具有细胞谷胱甘肽过氧化物酶(cGPX)活性的含硒抗体酶mHB4,mHB5和mHB7,活力分别为170,1867,32U/μmol.其中mHB5的活力是天然兔肝cGPX的0.32倍,m4A4的1.51倍.等离子体-质谱(ICP/MS)测得每分子含硒抗体酶分子中大约存在2个硒原子.mHB5的最适pH为8.6～8.8.在pH值范围为7.0和37℃条件下,mHB5催化GSH和H₂O₂或t-ROOH反应的二级速率常数为:_k+1(H₂O₂)9.71×10⁶L/(mol·min),_k+1(t-ROOH)5.99×10⁵L/(mol·min).mHB5使非酶催化反应速率提高了9.8×10⁶和3.7×10⁵倍.     

Isolation and characterization of an anti-recombinant erythropoietin single-chain antibody fragment using a phage display antibody library

The production of a large amount of specific antibodies against erythropoietin (EPO) is necessary for both clinical treatment and doping control. However, the weak immunogenicity of EPO and the side effects of excessive injection make the conventional immunological protocol rather inefficient and time-consuming. In this study, a single-chain antibody fragment of variable region (scFv) against recombinant human erythropoietin (rHuEPO) was produced after three rounds of panning a phage display antibody library. The selected scFv-B₂ was expressed in soluble form in Escherichia coli DH5α F′ and purified by His-bond nickel affinity chromatography with a yield of about 1–2 mg of antibody in 1 L of the culture supernatant. The molecular weight of the scFv was estimated to be 29 kDa by sodium dodecyl sulfate polyacrylamide gel electrophoresis and the affinity constant was found to be 1.0×10⁸ L mol⁻¹ based on a competitive indirect enzyme-linked immunosorbent assay (CI-ELISA). The potential ability of the scFvs for immunopurification of rHuEPO from related sample was demonstrated by using a double-antibody sandwich ELISA. The reported method is a very powerful tool to produce specific antibodies for rHuEPO detection demands.     

Selection,Expression and Purification of Human Abzyme Containing Selenium with Type Ⅰ Thyroxine Deiodinase Activity

Single-chain fragment variable(ScFv) antibodies with the substrate binding sites were obtained by repetitive selections from a semi-synthetic phage display antibody library against two haptens——thyroxine(T4) and O-methyl-T4(O-CH3-T4).The positive phage clones were determined by ELISA and then cloned into vector pET30a(+).The recombined plasmids were identified by DNA sequence analysis and transformed into E.coli BL21(DE3).The expressed proteins were isolated,purified,identified by Western blot analysis,and ...     

Identification of a Neutralizing scFv Binding to Human Vascular Endothelial Growth Factor 165 (VEGF165) Using a Phage Display Antibody Library

Vascular endothelial growth factor (VEGF) is a multifunctional cytokine that plays a major role in angiogenesis. Alternative splicing causes the production of several different isoforms (VEGF121, 145, 165, 183, 189, 206). VEGF is essential for tumor angiogenesis, and several studies have correlated elevated VEGF levels with tumor stage, metastases, and progression. We now report the isolation by phage display of human single-chain antibody fragment (scFv) anti-VEGF165. After four rounds of panning against VEGF165, 40 out of 90 phage clones displayed VEGF165-binding activity. One of the positive clones, designated B8, bound to VEGF165 with relatively high affinity and neutralized VEGF165 bioactivity in vitro. The B8 clone was expressed in the soluble form in Escherichia coli HB2151 and purified by immobilized metal affinity chromatography. The purified scFv recognized VEGF165 with the K _D of 1.80 × 10⁻⁸ M without cross-reaction to VEGF121. In addition to binding, the purified scFv could does-dependently inhibit VEGF165-induced human umbilical vein-derived endothelial cells proliferation. Together with its fully human mature, B8 scFv may have therapeutic implications in therapy of angiogenesis-dependent diseases.     

Selection of phage antibodies with GPX activity by combination of phage displayed antibody library with chemical modification and their characterization using a surface plasmon resonance biosensor

Glutathione peroxidase (GPX) is an important antioxidant enzyme, which plays an important role in scavenging reactive oxygen species. To obtain humanized GPX catalytic antibodies, the phage displayed human antibody library on the surface of the filamentous bacteriophage was used to select novel antibodies by repetitive screening. Phage antibodies B8, H6 and C1 with the GSH-binding site were obtained from the library by enzyme-linked immunosorbent assay (ELISA) analysis with four rounds of selection against three haptens, S-2,4-dinitrophenyl t-butyl ester [GSH-S-DNP-Bu (B)], S-2,4-dinitrophenyl t-hexyl ester [GSH-S-DNP-He (H)] and S-2,4-dinitrophenyl cycle-hexyl ester [GSH-S-DNP-cHe (C)], and characterized using surface plasmon resonance (SPR) biosensor. The gold layer was modified by dithiodiglycolic acid (DDA) and three haptens were easily attached to DDA by self-assembling to form a biosensor membrane. The membrane bounds specifically corresponding antibodies. The kinetic process of the reaction between phage antibodies and their haptens was studied by SPR biosensor. In order to improve selectivity, chemical modification was used to incorporate directly catalytic group selenocysteine (Sec) into selected phage clone B8, H6 and C1 to form Se-B8, Se-H6 and Se-C1, respectively. The GPX activities of Se-B8, Se-H6 and Se-C1 were found to be 3000, 2000 and 700 units/μmol, respectively. Compared with conventional ELISA analysis, the proposed method based on SPR biosensor is much more rapid and simpler.     

Screening of scFvs against cTnI from Phage Display Antibody Library and Their Expression in E.coli Rosetta

Introduction CardiactroponinI(cTnI),aspecificproteinof cardiacmusclecells,showsa40%dissimilarity withskeletaltroponinI(sTnI)inaminoacidse- quence.Moreover,humancardiacTnIhas31addi- tionalresiduesonitsN-terminalend,whichare notpresentinskeletalforms,thusprovidingahigh potentialforobtainingcardiac-specificantibod- ies[1,2].Themolecularweightofthisproteinis29 kDaandtherefore,itwillbereleasedreasonably rapidlyafteracutemyocardialinfarction(AMI). CTnIoftenappearsinbloodwithinafewhoursaf- ter…